These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12974196)

  • 1. Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity.
    Confino-Cohen R; Goldberg A
    Allergy Asthma Proc; 2003; 24(4):281-4. PubMed ID: 12974196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance.
    Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M
    J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe immediate reaction to nabumetone.
    Gonzalo-Garijo MA; Cordobés-Duran C; Lamilla-Yerga AM; Moreno-Gastón I
    J Investig Allergol Clin Immunol; 2007; 17(4):274-6. PubMed ID: 17694703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
    Gyllfors P; Bochenek G; Overholt J; Drupka D; Kumlin M; Sheller J; Nizankowska E; Isakson PC; Mejza F; Lefkowith JB; Dahlén SE; Szczeklik A; Murray JJ; Dahlén B
    J Allergy Clin Immunol; 2003 May; 111(5):1116-21. PubMed ID: 12743579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events.
    Freston JW
    Am J Med; 1999 Dec; 107(6A):78S-88S; discussion 89S. PubMed ID: 10628597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
    Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
    Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients.
    Martín-García C; Hinojosa M; Berges P; Camacho E; García-Rodriguez R; Alfaya T
    J Investig Allergol Clin Immunol; 2003; 13(1):20-5. PubMed ID: 12861847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.
    Takeuchi K; Smale S; Premchand P; Maiden L; Sherwood R; Thjodleifsson B; Bjornsson E; Bjarnason I
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):196-202. PubMed ID: 16469680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions.
    Quiralte J; Sáenz de San Pedro B; Florido JJ
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):63-6. PubMed ID: 12141722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
    Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
    J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
    Nosbaum A; Braire-Bourrel M; Dubost R; Faudel A; Parat S; Nicolas JF; Bérard F
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers.
    van Kraaij DJ; Hovestad-Witterland AH; de Metz M; Vollaard EJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):644-7. PubMed ID: 12047490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.
    Weaver AL; Messner RP; Storms WW; Polis AB; Najarian DK; Petruschke RA; Geba GP; Tershakovec AM
    J Clin Rheumatol; 2006 Feb; 12(1):17-25. PubMed ID: 16484875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria.
    Asero R
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):187-9. PubMed ID: 16937749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs.
    Nettis E; Colanardi MC; Ferrannini A; Tursi A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):29-33. PubMed ID: 15702812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs].
    Ahlbach S; Usadel KH; Kaufmann R; Boehncke WH
    Med Klin (Munich); 2003 Apr; 98(5):242-4. PubMed ID: 12721666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.